Back to results
US 7,442,812 B2Granted
Substituted benzopyrans as selective estrogen receptor-beta agonists
AssigneeEli Lilly and Company
InventorsGregory Lee Durst, Bryan Hurst Norman, Timothy Ivo Richardson
Life of this patent
Estimating the term…
Abstract
The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor β agonists for treating Estrogen Receptor β mediated diseases such as benign prostatic hyperplasia.
Claims7
A compound according to the formula:
- wherein
- G is C═O, CHOH, CF2, C(OH)CF3, CHCF3, C(OH)C1-C6alkyl, CH—OC1-C6alkyl, CH—O(CO)C1-C6alkyl, CHF, CHCN, CHC2-C4alkenyl, CHC2-C4alkynyl, CHbenzyl, C═CF2;
- or 4-(4-hydroxy-phenyl)-2-methylene-1,2,3,3a,4,9b-hexahydro-cyclopenta[c]chromen-8-ol;
- or a pharmaceutically acceptable salt thereof.
1 more element
Dependencies are inferred from the claim text.